Fungal fighter fails to finish Crohn's trial
NCT ID NCT04966585
Summary
This study tested whether an oral antifungal medication called posaconazole could help control active Crohn's disease. It specifically enrolled 10 adult patients who had both active Crohn's and a particular genetic marker thought to make them sensitive to a common skin fungus. The trial was designed to see if reducing this fungus would calm the immune system and improve gut inflammation, but the study was terminated early.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Cedars-Sinai Medical Center (CSMC)
Los Angeles, California, 90048, United States
-
Mayo Clinic
Rochester, Minnesota, 55901, United States
Conditions
Explore the condition pages connected to this study.